变应性鼻炎特异性免疫治疗疗效和依从性分析

邝立; 冯惠玲; 谢冰斌

doi:10.13201/j.issn.1001-1781.2012.02.009

变应性鼻炎特异性免疫治疗疗效和依从性分析

- 佛山市中医院耳鼻咽喉科(广东佛山, 528000)

详细信息

通讯作者: 邝立,E-mail:YE95226@126.com

中图分类号: R765.2

收稿日期: 2011-05-09

Efficacy and compliance of specific immunotherapy in allergic rhinitis

- Department of Otorhinolaryngology, Foshan Traditional Chinese Medical Hospital, Foshan, 528000, China

More Information

Corresponding author: KUANG Li, E-mail: YE95226@126.com

Received Date: 09 May 2011

摘要

摘要: 目的:探讨变应性鼻炎患者特异性免疫治疗的疗效、安全性及依从性。方法:对采用安脱达尘螨疫苗制剂进行免疫治疗的280例变应性鼻炎患者,通过等级评分观察其症状、体征及疗效。结果:对治疗1年以上患者的症状、体征积分等进行统计,治疗16周、6个月、1年后的总有效率分别为86.8%、70.4%、62.5%;280例患者治疗1年后停止治疗74例,依从率为73.6%。结论:对变应性鼻炎患者规范的特异性免疫治疗是一种安全性高且有效的对因治疗方法,在变应性鼻炎的综合治疗中值得重视和推广,同时要加强患者健康教育来提高治疗依从性。
- 特异性免疫治疗 /
- 鼻炎,变应性 /
- 疗效 /
- 依从性
Abstract: Objective: To evaluate the efficacy, safety and compliance of specific immunotherapy in allergic rhinitis.Method: Two hundred and eighty cases with allergic rhinitis were undertaken immunotherapy, and then were observed its symptoms, signs and treatment by graded score.Result: Total effective rate was 86.8%,70.4%,62.5% at 16 week, 6 months and 1 year after treatment. Of 280 patients treated, 74 patients stopped treatment after one year, compliance rate was 73.6%.Conclusion: Specific immunotherapy is a safe and effective treatment methods for allergic rhinitis and worthy of attention and promotion, while strengthening the health education is needed to improve treatment compliance of patients.
- specific immunotherapy /
- rhinitis,allergic /
- efficacy /
- compliance

HTML全文

参考文献(14)

[1]	BROZEK J L, BAENA-CAGNANIC E, BONINI S,et al. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update[J]. Allergy,2008,63:38-46.
[2]	中华耳鼻咽喉头颈外科杂志编委会,中华医学会耳鼻咽喉头颈外科鼻科学组.变应性鼻炎诊断和治疗指南(2009,武夷山)[J].中华耳鼻咽喉头颈外科杂志,2009,44(12):977-978.
[3]	BROZEK J L,BOUSQUET J,BAENA-CAGNANI C E,et al.Allergic rhinitis and its impact on asthma(ARIA) guidelines:2010 revision[J].J Allergy Clin Immunol,2010,126:466-476.
[4]	邝立,冯惠玲,梅晓峰,等.广东佛山地区1560例变应性鼻炎患者变应原点刺试验结果分析[J].临床耳鼻咽喉头颈外科杂志,2010,24(5):229-230.
[5]	冯惠玲,邝立,梅晓峰,等.佛山地区1293例变应性鼻炎患者辨证分型结果分析[J].中国中西医结合耳鼻咽喉科杂志,2010,18(5):251-252.
[6]	BOUSQUET J,VAN CAUWENBERGE P,KHAITAEV N.Allergic rhinitis and its impact on asthma[J]. Allery Clin Immunol,2001,108:147-334.
[7]	李响,朱福音.屋尘螨疫苗脱敏治疗远期临床效果观察[J].中国临床实用医学,2009,3(2):72-73.
[8]	陈久艳,徐吉成.安脱达标准化尘螨疫苗治疗儿童过敏性哮喘32例疗效观察[J].苏州大学学报(医学版),2009,29(6):1246-1247.
[9]	胡银亚,鲁杰. 变应原制剂脱敏治疗变应性鼻炎的疗效观察与护理[J]. 解放军护理杂志,2010,27(5):690-691.
[10]	韩虹,陈少华,邱前辉. 安脱达尘螨疫苗治疗变应性鼻炎的疗效及安全性评价[J].广东医学,2007,28(6):991-992.
[11]	符徵,蔡飞,孙亮,等.安脱达标准疫苗免疫治疗的安全性[J]. 国际耳鼻咽喉头颈外科杂志,2009,23(18):856-857.
[12]	陈利清,陈建强. 变应性鼻炎标准化尘螨变应原疫苗治疗[J].中国眼耳鼻喉科杂志,2010,10(2):112-113.
[13]	苏芳,谢景华,孟庆祥.粉尘螨疫苗治疗变应性鼻炎患者的依从性及相关因素分析[J].临床医学,2010,30(1):30-32.
[14]	蔡维云,洪立娜,孙维生.过敏性疾病脱敏依从性调查与分析[J].国际护理学杂志,2007,26(6):604-605.